Industries / Health / Pharmaceuticals
Manufacturing
Making a medicine at scale, the same way every time, under good manufacturing practice (GMP).
6
Milestones achieved, from 1910 to 2022.
1
To watch for: announced, not yet confirmed outside.
1
Open deliverables. Nobody has shipped them.
The road
AchievedWatch forOpen
Achieved
1910
A synthetic drug at scale
The chemical company Hoechst made Salvarsan in stainless steel containers with a yield just under 16%, and sealed the powder in ampoules under carbon dioxide so that air could not turn it into a toxic form. By November 1910 it was producing 12,000 to 14,000 ampoules a day.
Credit
Hoechst, with Paul Ehrlich
1912
Fever traced to the water
Patients given Salvarsan sometimes developed fever and shaking chills. Wilhelm Wechselmann suggested in 1910 that dead bacteria and fungi in the distilled water were the cause, and James McDonagh at London's Lock Hospital confirmed it by using re-distilled water.
LessonWhat goes into a dose besides the drug, even the water, has to be controlled.
Credit
Wilhelm Wechselmann, James McDonagh
1944
Penicillin in deep tanks
Pfizer turned an old Brooklyn ice plant into a penicillin factory, which opened on 1 March 1944 with fourteen 7,500-gallon tanks. It soon made more penicillin in one month than the company had made in all of 1943, and most of the penicillin that went ashore with Allied forces on D-Day came from it, according to the American Chemical Society, which named the work a National Historic Chemical Landmark.
Credit
Pfizer; Jasper Kane, who proposed the deep-tank method
1982
Human insulin from bacteria
The FDA approved Humulin, human insulin made by bacteria carrying the human insulin gene, in 1982. The US National Science Foundation calls it the first recombinant pharmaceutical approved in the United States. A Genentech and City of Hope team made the first such insulin, under a contract from Eli Lilly, then the main US maker of insulin from animals.
Credit
Genentech, City of Hope, Eli Lilly
2016
From batches to a line
Most medicines are made in batches: each step finishes for the whole lot before the next begins. In continuous manufacturing, material flows through all the steps without stopping. In April 2016 the FDA for the first time let a company, Janssen, switch an approved medicine, the HIV drug Prezista, from batch to continuous production. Vertex already made its cystic fibrosis drug Orkambi continuously.
Credit
Janssen; FDA
2022
Continuous manufacturing gets rules
ICH adopted Q13, a shared guideline for continuous manufacturing of drug substances and finished medicines, on 16 November 2022. It took effect in the EU on 10 July 2023.
Credit
ICH; EMA's CHMP
Watch for
Rules for AI in factories
The European Commission published a draft Annex 22 to the EU GMP guidelines, a dedicated annex on artificial intelligence in the making of medicines, together with revisions to the rules on computerised systems (Annex 11) and documentation (Chapter 4). Consultation ran from 7 July to 7 October 2025.
Achieved whenthe final annex is adopted into the EU GMP rules (EudraLex Volume 4) and takes effect.
Claimed by
European Commission, July 2025
Open
01
An open vial-inspection image set
A large, fully public set of labelled image sequences of glass vials, some clean and some with seeded defects such as floating particles, fibres and cracks, released with a baseline detection model and its scores. Traditionally, inspectors check injectable medicines for particles by rotating and tilting each container by hand.
The briefCredit · unclaimed
Open 01 · the brief
An open vial-inspection image set
The first to publish is credited on this line, and the deliverable moves from Open to Achieved.
What to build
A large, fully public set of labelled image sequences of glass vials, some clean and some with seeded defects such as floating particles, fibres and cracks, released with a baseline detection model and its scores. Traditionally, inspectors check injectable medicines for particles by rotating and tilting each container by hand.
Why it is still open
A 2024 study from the University of Modena and Reggio Emilia names the lack of publicly available datasets as the main gap in detecting particles in liquids, and released its own 46,094-image set only in part.
Built with what exists
vials filled with water only, never medicine; a phone or machine-vision camera; a turntable or a low-cost robot arm to spin and present each vial; open labelling software; an image model. Robot models that learn a task from a few demonstrations make the arm cheap to set up. The notes "Five demonstrations per task" (NVIDIA GR00T 2) and "No download" (LeRobot v0.7.0) cover such tools.
First step
Film 100 water-filled vials on a turntable, 50 of them with a seeded particle, and publish the pilot set with labels.
Done looks like
At least 5,000 vial sequences across 5 or more defect classes, each label checked by two people, released under an open licence with a baseline detector, and the baseline's accuracy confirmed by a second group.